As a phase 1 clinical trial, the goal is to learn more about the effects of the investigational HER2 targeted therapy and determine if it is safe for people with HER2 overexpression in solid tumors.
Study TherapyIf you are eligible and choose to join, participation will last for about 1 year. If you qualify, you will be asked to do the following:
Want more information about the study? Visit clinicaltrials.gov to learn more about the targeted HER2 clinical trial.
Find a Study Clinic